ethylmaleimide has been researched along with Lymphoma, Non-Hodgkin in 2 studies
Ethylmaleimide: A sulfhydryl reagent that is widely used in experimental biochemical studies.
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forsberg, AJ | 1 |
| Kagan, VE | 1 |
| Schroit, AJ | 1 |
| Prager, MD | 1 |
| Derr, I | 1 |
| Swann, A | 1 |
| Cotropia, J | 1 |
2 other studies available for ethylmaleimide and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
Thiol oxidation enforces phosphatidylserine externalization in apoptosis-sensitive and -resistant cells through a deltapsim/cytochrome C release-dependent mechanism.
Topics: Antibiotics, Antineoplastic; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Membrane; Cytochromes c | 2004 |
Immunization with chemically modified lymphoma cells.
Topics: Amides; Aminobenzoates; Animals; Antibody Formation; Cytotoxicity Tests, Immunologic; Disease Models | 1971 |